Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer

Seminars in Oncology

Volumn 26, Issue 3 SUPPL. 11, 1999, Pages 13-18

  Le Chevalier, T ^a   Berille, J ^a   Zalcberg, J R ^a   Millward, M J ^a   Monnier, A ^a   Douillard, J Y ^a   McKeage, M J ^a   James, R ^a   Soulas, F ^a   Loret, C ^a   Bougon, N ^a   Bizzari, J P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; AGED; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MIXTURE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; SURVIVAL ANALYSIS; TAXOIDS;

EID: 0032855665     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)